# A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

> **NCT04189705** · PHASE3 · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 392 (actual)

## Conditions studied

- Acute Gastritis
- Chronic Gastritis

## Interventions

- **DRUG:** MCT-SR
- **DRUG:** Mucosta Tab.

## Key facts

- **NCT ID:** NCT04189705
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-30
- **Primary completion:** 2020-04-23
- **Final completion:** 2020-04-23
- **Target enrollment:** 392 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04189705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04189705, "A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04189705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*